A powered balancing mobility device that can provide the user the ability to safely navigate expected environments of daily living including the ability to maneuver in confined spaces and to climb curbs, stairs, and other obstacles, and to travel safely and comfortably in vehicles. The mobility device can provide elevated, balanced travel.

A data system for managing the settings for configuring a hearing aid includes a hearing aid (10, 11) and a remote server (25). The hearing aid (10, 11) has a processor (121). a first memory segment (110-112) for storing said configuration settings, a transceiver (122) adapted for establishing a wireless connection to an Internet enabled personal communication device (13), and a second memory segment (114) for storing at least one security element. The remote server (25) is adapted to set up a secure session with said hearing aid via said personal communication device (13) acting as a gateway. The processor (121) allows said remote server (25) to edit said settings for configuring the hearing aid (10, 11) stored said first memory segment (110-112) during a secure session set up under control of said at least one security element stored in the second. memory segment (114).

An example operation may include one or more of extracting a data object from a machine-readable code. The data object can include fields of data signed with a digital signature of a private key, detecting an identifier of an issuer of the data object from the extracted data object, retrieving a public key from a blockchain based on the identifier of the issuer detected from the field of the extracted data object, and verifying the digital signature of the private key based on the fetched public key.

A system is provided for encoding genomics data for secure storage and processing. In particular, the system may comprise a client and server operating environment that uses a unique encoding algorithm to transform genomics data and/or metadata to produce encoded genomics data and/or metadata. In some embodiments, the encoded genomics data and/or metadata may be encrypted using one or more encryption algorithms. The encoded and/or encrypted genomics data may be stored on a secure server (e.g., a cloud environment) that may perform subsequent processing steps on the encoded and/or encrypted genomics data. Once the processing steps have been completed, the server may transmit one or more outputs associated with the genomics data and/or metadata to a client device. In this way, the system provides an efficient and secure way to store and process genomics data.

A system and method for homomorphic encryption in a healthcare network environment is provided and includes receiving digital data over the healthcare network at a data custodian server in a plurality of formats from various data sources, encrypting the data according to a homomorphic encryption scheme, receiving a query at the data custodian server from a data consumer device concerning a portion of the encrypted data, initiating a secure homomorphic work session between the data custodian server and the data consumer device, generating a homomorphic work space associated with the homomorphic work session, compiling, by the data custodian server, a results set satisfying the query, loading the results set into the homomorphic work space, and building an application programming interface (API) compatible with the results set, the API facilitating encrypted analysis on the results set in the homomorphic work space.

A computerized system and method to allow a safe, secure and efficient real-time access to the patient's private health records (PHR) stored in the encrypted format in a remote Private Health Vault (PHV) database. The system uses patient's private encryption key for encrypting and decrypting PHR stored in the PHV, and the patient controls access to the PHR and authorizes by electronic communications with the PHV server to allow doctors to have limited in duration access to the patient PHR. The patient's private keys may be stored in a remote Key Bank database, separately form the PHV database, and the location of the patient's PHV data may also require transmission of the location id from a separate Mapping server. Additional security is also provided by determining digital proximity of the doctor's and patient's mobile devices to the node device in the doctor's office, and terminating access when patient leaves the facilities. It also utilizes 2-way digital token exchange and confirmation of the exchange between the patent and doctor, as well as digital fingerprinting for the confirmation of identity.

The present disclosure relates to a method for vaccination management including at least: transmitting, by a medical institution device, a vaccination certificate issuance request, an identity certification verifiable credential (VC) for a user, a vaccination agency VC for a medical institution, and a digital signature of the medical institution, to a trusted institution server; verifying, by the trusted institution server, the vaccination agency VC based on a digital signature of a VC issuer included in the vaccination agency VC and the identifier of the trusted institution stored in a public distributed ledger; determining, by the trusted institution server, whether there is an authority for the vaccination certificate issuance request based on the vaccination agency VC and a medical institution database stored in the trusted institution server; and issuing, by the trusted institution server, a vaccination certification VC.

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.

Methods and apparatus provide communications among respiratory therapy device (TD), server and intermediary (e.g., a control device (CTLD) for the therapy device) to improve security. More secure communication channel(s) may be established using shared secrets derived with different channels. The communications may include transmitting therapy data from TD to server for authentication. The CTLD may receive the data and a nonce from a server. The CTLD receives from the TD a signing key dependent on the nonce and a secret shared by TD and server. The CTLD generates an authorisation code with received therapy data and the key for authentication of the data by the server upon its receipt of the code and data. The server computes (1) a key from the nonce and the secret known to TD, and (2) another authorisation code from received therapy data and the key. Data authentication may involve comparing received and computed codes.

Various embodiments provide for decentralized crowd sourced generation of recommendation data objects. An example apparatus receives, originating from an external computing device, a recommendation data object request, the recommendation data object request comprising a user identifier and one or more user attributes. The example apparatus may further retrieve, based on a predictive recommendation model, one or more therapy identifiers associated with a therapy efficacy score exceeding a therapy efficacy score threshold for attributes of a first attributes set associated with a first cluster identifier, the first attributes set comprising one or more of the one or more user attributes. The predictive recommendation model is trained based at least in part on trusted efficacy blocks of a distributed ledger, where the trusted efficacy blocks are added to the distributed ledger when a number of therapy efficacy transaction blocks associated with a given therapy identifier and having a therapy efficacy score exceeding a therapy efficacy score threshold meets or exceeds a therapy efficacy transaction block threshold. The example apparatus may further transmit, to the external computing device, a recommendation data object configured for rendering for display via a display device of the external computing device, where the recommendation data object comprises one or more of the one or more therapy identifiers.